Back to Search Start Over

Nutrition and NSCLC; Should We Administer Food Supplements?

Authors :
Κonstantinos Romanidis
Paul Zarogoulidis
Kosmas Tsakiridis
Haidong Huang
Konstantinos Sapalidis
Isaak Kesisoglou
Wolfgang Hohenforst-Schmidt
Christoforos Kosmidis
Anastasios Vagionas
Source :
Current Pharmaceutical Design. 27:3602-3608
Publication Year :
2021
Publisher :
Bentham Science Publishers Ltd., 2021.

Abstract

Non-small cell lung cancer is usually diagnosed at the advanced stage of the disease. We have novel diagnostic tools. However, prevention is still the best way to deal with this disease. Patients receive different treatments with different adverse effects. Targeted treatment with tyrosine kinase inhibitors and immunotherapy have entered everyday clinical practice. The nutritional status of a patient plays a crucial role in the treatment of the patient. Cachexia is observed in most cancer patients, and it has been identified as an independent factor in the overall survival of the patient. The improvement of nutritional status and metabolism directly impacts the quality of life, daily living, and overall survival of a lung cancer patient. We conducted a search on PubMed and Scopus and identified relevant publications. In this review, we will focus on the nutritional status of NSCLC patients and how food supplements assist in the QoL based on published literature. Additional information from other cancer types will be included where necessary.

Details

ISSN :
13816128
Volume :
27
Database :
OpenAIRE
Journal :
Current Pharmaceutical Design
Accession number :
edsair.doi.dedup.....e1e70a66d3a562a7ccf306be6c78e637